SC ISRAEL IV GENPAR, LTD. — 13F Portfolio

SC ISRAEL IV GENPAR, LTD. is a general-partner entity associated with a Sequoia-branded Israel-focused venture capital fund, based in Herzliya, Israel. The vehicle functions as a managing entity for a series of private funds that invest primarily in early- and growth-stage technology companies originating from the Israeli innovation ecosystem and, selectively, from other global tech hubs. As a general partner within a larger venture platform, SC ISRAEL IV GENPAR, LTD. oversees capital deployed into privately held, high-growth businesses across software, cybersecurity, semiconductors, fintech, and adjacent verticals. Over time, a subset of these portfolio companies list on U.S. exchanges, typically NASDAQ or the NYSE. When that occurs, the GP may continue to hold a meaningful equity stake through and beyond the IPO, which in turn gives rise to reportable U.S.-listed holdings. For U.S. regulatory purposes, SC ISRAEL IV GENPAR, LTD. appears as an institutional investment manager and files Form 13F with the Securities and Exchange Commission under CIK #1611353. These quarterly filings disclose the entity’s reportable long positions in U.S.-listed equities and certain equity-like instruments. They represent only the public-market portion of the broader Israel-focused venture portfolio; private investments, non-U.S. listings that do not trade in the U.S., and any derivatives or structured positions fall outside the 13F dataset. On a research or analytics platform, all of the entity’s 13F submissions can be assembled into a continuous 13F History, providing a structured, time-series record of how its disclosed long U.S.-listed holdings have evolved as individual portfolio companies move from private to public status and as positions are seasoned or exited.

The underlying strategy of SC ISRAEL IV GENPAR, LTD. is that of a classic, high-conviction venture capital fund focused on Israeli and closely related technology businesses. While the formal mandate is defined at the fund level, the practical characteristics are well aligned with the broader Sequoia-style venture model: - Early- and expansion-stage investment in category-defining technology companies with defensible intellectual property, strong technical teams, and significant global market potential. - Deep, thesis-driven research on secular technology trends—such as cybersecurity, cloud and SaaS infrastructure, data and AI, enterprise software, communications, and select hardware and semiconductor opportunities. - Active partnership with founders and management, including board participation, strategic guidance, and assistance with hiring, scaling, and global go-to-market initiatives. - Long-horizon ownership, with capital often deployed over multiple rounds and held through IPO and sometimes well into the public lifecycle, subject to liquidity, valuation, and portfolio-construction considerations. The subset of this activity that appears in Form 13F reflects the crossover and public phase of the strategy. Typical 13F-disclosed positions for SC ISRAEL IV GENPAR, LTD. are: - U.S.-listed shares of former private portfolio companies following IPOs or direct listings. - Occasionally, additional purchases or partial sales in the open market as the GP manages position size, liquidity, or long-term exposure. Because portfolio construction is driven at the venture-fund level, the 13F portfolio is usually concentrated in a relatively small number of high-conviction names rather than diversified across hundreds of securities. A holdings-based review of the fund’s 13F Portfolio Composition over time allows allocators to see how core Israeli and global tech themes translate into public equity exposure, how long post-IPO positions tend to be held, and how concentration in individual winners or laggards evolves as companies mature.

SC ISRAEL IV GENPAR, LTD., filing with the SEC under CIK #1611353, represents the 13F-visible edge of an Israel-centric venture capital strategy operating within a larger Sequoia-branded platform. Its regulatory filings provide a recurring, position-level record of the fund’s residual and active stakes in U.S.-listed technology and innovation-led companies that originated as private investments. By aggregating these filings into a unified dataset, an analytics platform can construct a 13F-based Historical Track Record that mirrors a portfolio holding SC ISRAEL IV GENPAR, LTD.’s disclosed positions between quarter-ends. Examining that reconstructed capital trajectory alongside changes in 13F Portfolio Composition—issuer concentration, sector mix within technology, and the timing of entries and exits—helps allocators understand how the public portion of the venture portfolio has behaved across different equity and rate regimes. Overlaying diagnostics such as Max Drawdown Depth and a holdings-derived Sharpe Ratio adds quantitative context on the variability and risk-adjusted character of this long-only, 13F-implied stream. These analytics do not replace the need to analyze private portfolio companies, fund terms, or early-stage deal flow, but they provide an independent, public-data-based lens on how SC ISRAEL IV GENPAR, LTD.’s realized public exposures respond to shifts in market sentiment toward growth, technology, and the Israeli innovation ecosystem. The central analytical question for allocators is how closely the regime sensitivity implied by this 13F-based reconstruction—across tech booms and corrections, IPO windows, and changing risk appetites for high-growth names—maps onto the behavior and capital trajectory of the fund’s much larger, less liquid private holdings over a full venture capital cycle.

The economic risk profile of SC ISRAEL IV GENPAR, LTD. at the fund level is dominated by venture capital dynamics: technological execution risk, product–market fit, competitive displacement, financing and dilution risk, and exit timing. Company-level outcomes can be highly skewed, with a small number of outsized winners often compensating for a meaningful incidence of flat or unsuccessful investments. The Form 13F disclosures isolate only the public, long-equity portion of that venture portfolio. Within this narrower lens, observable risk characteristics include: - Sector and thematic concentration: U.S.-listed holdings are typically clustered in technology and tech-enabled sectors—software, cybersecurity, communications, semiconductors, and internet platforms—with limited diversification into more defensive or non-tech areas. - Geographic and ecosystem concentration, given the emphasis on companies with deep links to the Israeli tech ecosystem, even when listed in the U.S. - Higher volatility relative to broad benchmarks, as many portfolio companies may still be in earlier stages of their commercial and financial maturity at the time they are public. - Single-name risk, because a small number of positions can represent a large share of disclosed capital and be sensitive to earnings surprises, competitive developments, or regulatory changes. By treating each 13F report as a quarter-end snapshot and running Performance Backtests Online, an allocator can build a synthetic, long-only capital path that assumes SC ISRAEL IV GENPAR, LTD.’s disclosed positions are held between filings. From this reconstructed stream, metrics such as overall volatility, beta to technology- and growth-oriented indices, and Max Drawdown Depth can be estimated, providing a view of the worst peak-to-trough contractions for this stylized public-equity sleeve. A holdings-derived Sharpe Ratio offers a concise indication of risk-adjusted outcomes for this 13F-based replication. These diagnostics are inherently partial. Form 13F does not reveal the large body of private investments that drive most of the fund’s value-creation potential, nor any structured terms, preferred equity protections, or derivative overlays that might shape outcomes. In addition, intra-quarter trading around lock-ups and liquidity events is not captured. Consequently, 13F-based risk analytics should be interpreted as describing only the unhedged, U.S.-listed component of a broader venture-capital program.